Page 72

Marzo_2017

artículo de investigación Trastorno depresivo mayor en el nivel secundario de atención - L. Salvo et al 13. Tranter R, O’Donovan C, Chandarana P, Kennedy S. Prevalence and outcome of partial remission in depression. 342 J Psychiatry Neurosci 2002; 27 (4): 241-7. 14. Ruiz H, Silva H, Miranda E. Clinical and psychometric diagnosis of depression in general medical patients. Rev Med Chile 2001; 129 (6): 627-33. 15. Ojeda C, Silva H, Cabrera J, Tchimino C, De la Carrera C, Molina A. Validez interna y concurrente de una escala breve autoadministrada de siete ítems para la depresión, evaluada en relación a los inventarios de Beck y Hamilton. Estudio preliminar. Rev Chil Neuro-Psiquiat 2003; 41 (1): 31-8. 16. Baader T, Molina J, Venezian S, Rojas C, Farías R, Fierro-Freixeneta C, et al. Validación y utilidad de la encuesta PHQ-9 (Patient Health Questionnaire) en el diagnóstico de depresión en pacientes usuarios de atención primaria en Chile. Rev Chil Neuro-Psiquiat 2012; 50 (1): 10-22. 17. Hardeveld F, Spijker J, De Graaf R, Nolen W, Beekman A. Prevalence and predictors of recurrence of major depressive disorder in the adult population. Acta Psychiatr Scand 2010; 122: 184-91. 18. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006; 163 (1): 28-40. 19. Holma KM, Holma IA, Melartin TK, Rytsala HJ, Isometsa ET. Long-term outcome of major depressive disorder in psychiatric patients is variable. J Clin Psychiatry 2008; 69: 196-205. 20. Anderson IM, Ferrier IN, Baldwin RC, Cowen PJ, Howard L, Lewis G, et al. Evidence -based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol 2008; 22: 343- 96. 21. Wang J, Patten S, Currie S, Sareen J, Schmitz N. Predictors of 1-year outcomes of major depressive disorder among individuals with a lifetime diagnosis: a population based study. Psychol Med 2012; 42: 327-34. 22. Cayún G, Cantrell R, Zarotsky V, Haynes V, Phillips G, Alatorre C, et al. Comprehensive review of factors implicated in the heterogeneity of response in depression. Depress anxiety 2012; 29: 340-54. 23. Novick D, Hong J, Montgomery W, Dueñas H, Gado M, Haro JM. Predictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational study. Neuropsychiatr Dis Treat 2015; 11: 197-205. 24. Ohayon MM, Schatzberg AF. Prevalence of depressive episodes with psychotic features in the general population. Am J Psychiatry 2002; 159: 1855-61. 25. Gournellis R, Lykouras L. Psychotic (delusional) major depression in the elderly: A review. Curr Psychiatry Rev 2006; 2: 235-44. 26. Ministerio de Salud de Chile. Guía clínica AUGE Depresión en personas de 15 y más. Series guías clínicas Minsal. Santiago de Chile: Minsal; 2013. 27. Alvarado R, Rojas G. El programa nacional para el diagnóstico y tratamiento de depresión en atención primaria: una evaluación necesaria. Rev Med Chile 2011; 139: 592-9. 28. Thase ME: The multifactorial presentation of depression acute care. J Clin Psychiatry 2013; 74 (suppl 2): 3-8. 29. Roca M, Monzón S, Vives M, López-Navarro E, Garcia Toro M, Vicens C, et al. Cognitive function after clinical remission in patients with melancholic and non-melancholic depression: a 6 month follow-up study. J Affect Disord 2015; 171: 85-92. 30. Baumeister H, Parker G. Meta-review of depressive subtiping models. J Affect Disord 2012; 139: 126-40. 31. Parker G, Fink M, Shorter E, Taylor MA, Akiskal H, Berrios G, et al. Issues for DSM-5 whither melancholia? The case for its classification as a distinct mood disorder. Am J Psychiatry 2010; 167: 745-7. 32. American Psychiatric Association: Practice Guideline for the treatment of patients with major depressive disorder. Third Edition. Washington, DC: American Psychiatric Association; 2010. 33. Rakofsky JJ, Schettler PJ, Kinkead BL, Frank E, Judd LL, Kupfer DJ, et al. The prevalence and severity of depressive symptoms along the spectrum of unipolar depressive disorders: a post hoc analysis. J Clin Psychiatry 2013; 74 (11): 1084-91. 34. Eaton WW, Shao H, Nestadt G, Lee HB, Bienvenu OJ, Zandi P. Population-based study of first onset and chronicity in major depressive disorder. Arch Gen Psychiatry 2008; 65 (5): 513-20. 35. Skodol A, Grilo C, Reyes K, Geier T, Grant B, Hasin D. Relationship of personality disorders to the course of major depressive disorder in a nationally representative sample. Am J Psychiatry 2011; 168: 257-64. 36. Wilkinson P, Dubicka B, Kelvin R, Roberts Ch, Goodyer I. Treated depression in adolescents: predictors of outcome at 28 weeks. BJP 2009, 194: 334-41. 37. Kessler RC, Bromet EJ. The epidemiology of depression across cultures. Annu Rev Public Health 2013; 34: 119- 38. 38. Williams MD, Harris R, Dayan CM, Evans J, Gallache J, Ben-Shlomo Y. Thyroid function and the natural history Rev Med Chile 2017; 145: 335-343


Marzo_2017
To see the actual publication please follow the link above